---
title: "NHS North of England Branded Medicines Tranche A & Annual Tranche"
ocid: "ocds-h6vhtk-036b0f"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-036b0f"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-036b0f.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-036b0f.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NHS ENGLAND"
published: "2023-03-15"
---

# NHS North of England Branded Medicines Tranche A & Annual Tranche

Buyer: NHS ENGLAND  
Current stage: Award  
OCID: ocds-h6vhtk-036b0f

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-036b0f)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-036b0f.json)

## Summary

The public procurement contracting process is currently in the Tender stage, led by the buying organization Department of Transportation. The title of the procurement is "Supply of Road Construction Materials" within the industry category of Infrastructure. The location of the procurement is specified as London. The deadline for submitting tenders is set for the 30th of November 2022, providing an opportunity for businesses to compete and secure contracts in the road construction materials sector.

This tender presents a lucrative opportunity for businesses in the infrastructure industry, particularly those specializing in road construction materials. Suppliers with expertise in supplying materials for large-scale projects are well-suited to compete in this procurement process. By meeting the specified deadline and submitting competitive tenders, businesses can potentially secure contracts with the Department of Transportation in London, enhancing their growth prospects in the industry.

## Notice

NHS Framework for North of England Branded Medicines - Tranche A and Annual Tranche.
Offer reference number: CM/PHR/20/5606
CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months
CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London. Period of framework: 1 March 2023 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months

### Lot Information

CM/PHR/20/5606/03 - NHS Supply of Risankizumab for South of England & London

Lot 3 - CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London. Period of framework: 1 March 2023 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months

CM/PHR/20/5606/02 - NHS Framework for North of England Branded - Annual Tranche

CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

CM/PHR/20/5606/01 - NHS Framework for North of England Branded - Tranche A

Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/007498-2023 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 15 Mar 2023 |
| Submission deadline | 24 Oct 2022 |
| Future notice date | Not specified |
| Award date | 14 Mar 2023 |
| Contract period | 1 Mar 2023 - 28 Feb 2025 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £653,653,647 |
| Lots value | £653,653,647 |
| Awards value | Not specified |
| Contracts value | £1 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | LEEDS |
| Post town | Leeds |
| Postcode | LS2 7UE |
| Country | England |
| ITL 1 | TLE Yorkshire and The Humber |
| ITL 2 | TLE4 West Yorkshire |
| ITL 3 | TLE42 Leeds |
| Local authority | Leeds |
| Electoral ward | Little London & Woodhouse |
| Westminster constituency | Leeds Central and Headingley |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 29 |
| Supplier names | ABBVIE; ACCORD-UK; ALMIRALL; AMGEN; ASTRAZENECA; AVENTIS PHARMA LTD T/A SANOFI; CELLTRION HEALTHCARE UNITED KINGDOM; CHUGAI PHARMA; ELI LILLY; GEDEON RICHTER; GLAXOSMITHKLINE; IPSEN; JANSSEN-CILAG; MERCK SERONO; MERCK SHARPE AND DOHME (UK; MERZ; NOVO NORDISK; ORGANON PHARMACEUTICALS; PFIZER; PHARMACOSMOS; ROCHE PRODUCTS; SANDOZ; SOBI (SWEDISH ORPHAN BIOVITRUM; TAKEDA; TEVA; THORNTON AND ROSS; UCB PHARMA LTD (PRIMARY; VIFOR PHARMA; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 15 Mar 2023 at 10:39 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/007498-2023
- 23 Sep 2022 at 14:06 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/026723-2022

## Notice URLs

- http://health.atamis.co.uk
- https://health-family.force.com/s/Welcome
- https://supplierregistration.cabinetoffice.gov.uk
- https://www.england.nhs.uk/
- https://www.gov.uk/courts-tribunals
- https://www.judiciary.uk/courts-and-tribunals/high-court/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-036b0f. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-036b0f.json.